Type / Class
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
Shares outstanding
49.7M
Number of holders
74
Total 13F shares, excl. options
21.8M
Shares change
+1.7M
Total reported value, excl. options
$366M
Value change
-$84.2M
Put/Call ratio
0.1
Number of buys
44
Number of sells
-50
Price
$16.78

Significant Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q2 2022

121 filings reported holding BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share as of Q2 2022.
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21.8M shares of 49.7M outstanding shares and own 43.93% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (2.9M shares), Logos Global Management LP (1.7M shares), Point72 Asset Management, L.P. (1.45M shares), JANUS HENDERSON GROUP PLC (1.37M shares), RTW INVESTMENTS, LP (1.28M shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (1.15M shares), Paradigm Biocapital Advisors LP (1.05M shares), SAMLYN CAPITAL, LLC (1.04M shares), SV Health Investors, LLC (907K shares), and EVENTIDE ASSET MANAGEMENT, LLC (854K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.